Risperidone Dosing Recommendations for Acute Hyperactive Delirium

Starting Dose and Administration

• Initiate treatment with 0.5 mg oral risperidone as a single dose for acute agitation; repeat dosing every 12 hours may be used if scheduled administration becomes necessary. 1
• Use the orally disintegrating tablet formulation when patients have difficulty swallowing; risperidone is available only via the oral route (no parenteral form). 1

Age‑Specific Dosing Adjustments

Adults < 65 years

• The standard starting dose of 0.5 mg oral is appropriate for younger adults. 1

Adults ≥ 65 years

• Mandatory dose reduction is required in older adults; begin at 0.5 mg or less. 1

Maximum Dose and Titration

• Do not exceed 6 mg per 24 hours to limit the risk of extrapyramidal symptoms. 1
• Titrate cautiously in 0.25–0.5 mg increments based on clinical response and tolerability. 1

Duration of Treatment

• Start risperidone on a prn (as‑needed) basis; transition to scheduled dosing only if persistent distressing symptoms require it, and limit the duration to the shortest feasible period. 1

Special Population Adjustments

• Severe renal impairment – reduce the dose. 1
• Severe hepatic impairment – reduce the dose. 1
• Frail patients or those with chronic obstructive pulmonary disease – consider a lower starting dose of 0.25–0.5 mg, similar to dosing in the elderly. 2

Safety Considerations

Common Adverse Effects

• Possible adverse effects include insomnia, agitation, anxiety, drowsiness, and orthostatic hypotension. 1
• The risk of extrapyramidal symptoms rises markedly when doses exceed 6 mg/24 h. 1

Dosing Errors to Avoid

• Do not exceed the recommended initial or maximum doses; dose overshoot is a frequent drug‑related problem in older adults. 1
• Avoid concurrent use with high‑dose olanzapine, as fatal outcomes have been reported. 1
• Do not combine risperidone with benzodiazepines in older adults unless treating alcohol or benzodiazepine withdrawal, because benzodiazepines increase delirium incidence, duration, and risk of paradoxical agitation. 3

Contraindications / Cautions

• Use caution in patients with severe pulmonary insufficiency, severe liver disease, or myasthenia gravis (unless the patient is imminently dying). 1

Monitoring Requirements

• Perform daily assessments for oversedation, orthostatic hypotension, and extrapyramidal symptoms. 1
• Monitor for paradoxical agitation, which occurs in roughly 10 % of older adults receiving psychotropic medications. 3
• Continuously evaluate fall risk in elderly patients. 3
• Reassess the need for continuation daily; antipsychotics are not licensed for delirium management and should be used only when clinically necessary. 1